WADDELL FREDERICK H 4
4 · AbbVie Inc. · Filed May 12, 2026
Research Summary
AI-generated summary of this filing
AbbVie (ABBV) Director Frederick H. Waddell Receives RSU Award
What Happened
Frederick H. Waddell, a director of AbbVie Inc. (ABBV), received a grant of 1,118 restricted stock units (RSUs) on May 8, 2026. The grant was reported as an award (transaction code A) at a reported price of $0.00 — these are compensation awards, so no shares were bought or sold and no cash exchanged.
Key Details
- Transaction date: 2026-05-08 — Grant of 1,118 RSUs at $0.00 per unit.
- Filing date / timeliness: Form 4 filed 2026-05-12; this filing is timely (filed within required business days).
- Shares owned after transaction: Not disclosed in this filing.
- Footnote: The RSUs were awarded under the AbbVie Amended & Restated 2013 Incentive Stock Program and will be paid one-for-one in AbbVie common stock upon the earlier of the director’s separation from service, death, or a change in control.
Context
RSU grants are a form of compensation and typically vest or convert to shares under specified conditions; they do not represent an immediate market purchase or sale. Such awards are common for directors and do not by themselves indicate the insider is increasing or decreasing exposure to the company's stock.
Insider Transaction Report
Form 4
AbbVie Inc.ABBV
WADDELL FREDERICK H
Director
Transactions
- Award
Common Stock, $0.01 par value
[F1]2026-05-08+1,118→ 30,076 total
Footnotes (1)
- [F1]These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for Frederick H. Waddell|2026-05-12